1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-13609S3 Deflazacort-d3-1-1

地夫可特-d3; 地氟可特-d3; 地恶唑可特-d3; 地拉扎可-d3; 去氟可特-d3

Isotope-Labeled Compounds; Glucocorticoid Receptor

Inflammation/Immunology

2025-07 Deflazacort-d3-1-1
HY-W740050 Ipratropium-d3 Iodide-1

Isotope-Labeled Compounds

Others

2025-07 Ipratropium-d3 Iodide-1
HY-W745290 Asimadoline-d5 Hydrochloride-1

Isotope-Labeled Compounds

Others

2025-07 Asimadoline-d5 Hydrochloride-1
HY-W753694 11-Hydroxytestosterone-d4-1

Isotope-Labeled Compounds

Others

2025-07 11-Hydroxytestosterone-d4-1
HY-403733A (–)-JJ-450-1

Androgen Receptor

Cancer

2025-07 (–)-JJ-450-1
HY-W704658 2,4,6-Trimethylbenzeneamine-d11

Isotope-Labeled Compounds

Others

2025-07 2,4,6-Trimethylbenzeneamine-d11
HY-W743936 Fosaprepitant-d4 Dimeglumine-1

Isotope-Labeled Compounds

Others

2025-07 Fosaprepitant-d4 Dimeglumine-1
HY-W653877 Oseltamivir-d3 Phosphate-1

奥司他韦-d3 磷酸盐

Isotope-Labeled Compounds

Others

2025-07 Oseltamivir-d3 Phosphate-1
HY-W767223 rac 1-Palmitoyl-2-chloropropanediol-d5-1

Isotope-Labeled Compounds

Others

2025-07 rac 1-Palmitoyl-2-chloropropanediol-d5-1
HY-168345A Ap4dT-1

DNA/RNA Synthesis

Others

2025-07 Ap4dT-1
HY-171983 RSV-IN-13-1

RSV

Infection

2025-07 RSV-IN-13-1
HY-174905 Quecitinib

JAK; Cytochrome P450

Inflammation/Immunology

2025-07 Quecitinib
HY-174927E DBCO-PEG-Maleimide (MW 3400)

Biochemical Assay Reagents

Others

2025-07 DBCO-PEG-Maleimide (MW 3400)
HY-174967A 4-Arm-PEG-OH (MW 5000)

Biochemical Assay Reagents

Others

2025-07 4-Arm-PEG-OH (MW 5000)
HY-W190743 Br-PEG8-OH

Biochemical Assay Reagents

Others

2025-07 Br-PEG8-OH
HY-NP0194B C1q Protein (Rabbit)

Complement System

Inflammation/Immunology

2025-07 C1q Protein (Rabbit)
HY-174932 Amino-PEG18-t-butyl ester

Biochemical Assay Reagents

Others

2025-07 Amino-PEG18-t-butyl ester
HY-174960A 6-Arm-PEG-FA (MW 600)

Biochemical Assay Reagents

Others

2025-07 6-Arm-PEG-FA (MW 600)
HY-P991621 EOS006215

TREM receptor

Cancer

2025-07 EOS006215
HY-122844B Ifebemtinib tosylate

FAK

Cancer

2025-07 Ifebemtinib tosylate